The Global Extracorporeal Membrane Oxygenation (ECMO) Market was valued at about USD 308 million in 2023. It is expected to grow to roughly USD 446 million by 2030, with a CAGR of around 5.5% during the forecast period from 2023 to 2030.

This growth comes from the rising rates of cardiopulmonary and respiratory diseases, increased use of ECMO technology in critical care, and improvements in ECMO systems such as portable devices and AI monitoring. The market growth is also supported by better healthcare infrastructure and greater awareness of ECMO's benefits around the world.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/extracorporeal-membrane-oxygenation-market?ram

Key Developments:

United States: Extracorporeal Membrane Oxygenation (ECMO)

- October 2025: Getinge Group and Medtronic launched next-generation portable ECMO systems. These systems feature better oxygenator efficiency and integrated patient monitoring, leading to more uses in emergency and transport situations.

- September 2025: LivaNova introduced an ECMO platform with AI-based flow management to improve treatment and reduce complications. It has gained traction in specialized cardiac surgery centers.

- August 2025: Edwards Lifesciences enhanced ECMO program support by offering advanced training and digital workflow tools. This allows for wider deployment across new hospital networks.

- July 2025: Inspira Technologies teamed up with OXY B.H.N. Ltd. to develop a compact ECMO system for critical care units with limited space and resources.

Japan: Extracorporeal Membrane Oxygenation (ECMO)

- October 2025: Terumo Corporation led the development of bio-compatible ECMO circuit parts designed for long-term use in neonatal and pediatric care, improving treatment safety.

- September 2025: Toshiba Medical Systems worked with regional hospitals to test AI-based patient monitoring systems for ECMO. This partnership aims to enhance response times and clinical results.

- August 2025: Fujifilm Healthcare started a program to improve ECMO training and certification, responding to the rising demand due to broader clinical indications.

- July 2025: Joint R&D between Japanese universities and medical device companies concentrated on enhancing oxygenator lifespan and minimizing blood trauma during ECMO therapy.

Recent Mergers and Acquisitions (M&A):

United States: Extracorporeal Membrane Oxygenation (ECMO)

- October 2025: Getinge Group acquired a startup focused on miniaturized ECMO pumps for transport and ambulatory applications.

- August 2025: Medtronic and LivaNova formed a strategic partnership to develop integrated ECMO and cardiac support platforms aimed at simplifying procedures.

Japan: Extracorporeal Membrane Oxygenation (ECMO)

- October 2025: Terumo Corporation merged with a regional biotech company to speed up the development of advanced biomaterials for ECMO circuits that offer more durability and biocompatibility.

- August 2025: Toshiba Medical Systems partnered with a robotics firm to create automated ECMO system management solutions for critical care automation.

Key Players:

- Terumo Corporation

- Medtronic Plc

- Spectrum Medical

- Getinge Inc.

- OriGen Biomedical

- MicroPort Scientific Corporation

- XENIOS AG

- MC3 Cardiopulmonary

- Abiomed Inc.

- Hemovent GmbH

Market Dynamics and Growth Drivers:

-Rising Burden of Respiratory and Cardiac Failure: As conditions like acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), severe pneumonia, cardiogenic shock, and post-cardiotomy failure become more common, hospitals are using ECMO as a rescue therapy when traditional ventilation or circulatory support does not work.

-Technological Advancements & Product Innovation: Improvements in ECMO systems, such as smaller and more portable machines, better oxygenators, pumps with improved biocompatibility, coated cannulas, and monitoring and automation features, are allowing the use of ECMO to spread beyond major centers into more ICU settings and transport.

-Expansion of Critical Care Infrastructure & Government Support: Many health systems are investing in advanced life-support technologies, setting up more dedicated ECMO centers, and creating reimbursement policies or funding to make ECMO easier to access. This is helping the market grow, especially in developing regions.

-Extended Indications & Bridging Applications: ECMO is being used more widely, not just for traditional cases of lung or heart failure but also as a bridge to lung or heart transplant, for extracorporeal cardiopulmonary resuscitation (ECPR), and in transport or ambulance settings. These expanded applications are driving demand.

-Aging Population and Growing Surgical Volumes: An older population with a higher rate of cardiovascular and respiratory diseases, along with a rise in complex cardiac and lung surgeries, is increasing the demand for ECMO therapy.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=extracorporeal-membrane-oxygenation-market?ram

Growth Forecast Projected:

The Global Extracorporeal Membrane Oxygenation Market is set to grow significantly from 2024 to 2031. In 2023, the market is steadily progressing. As key players adopt more strategies, growth will likely continue through the forecast period.

Research Process:

The research report on the Global Extracorporeal Membrane Oxygenation Market used both primary and secondary data sources. The process examined various factors affecting the industry, including government regulations, market conditions, competition, historical data, and technological advancements. It also looked at upcoming developments, market volatility, prospects, potential barriers, and challenges.

Key Segments:

- By Type: Venoarterial (VA) ECMO, Venovenous (VV) ECMO

- By Age Group: Children, Adult

- By Application: Respiratory, Cardiac, ECPR

- By End User: Hospitals, Specialty Clinics, Others

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.